According to the Market Statsville Group (MSG), the Global pathogen reduction system Market was valued at USD 1,480.02 million in 2023 and is expected to grow from USD 1,781.94 million in 2024 to USD 5,426.28 million by 2033, by exhibiting a CAGR of 20.4% during the forecast period (2024-2033)
Pathogen reduction systems (PRS) are critical in various industries, especially in healthcare, food safety, and blood management, to ensure the safety and quality of products by reducing or eliminating harmful microorganisms. Pathogen reduction systems can be defined as the technologies or devices that can be widely applied to the market for reducing the contamination risk. Strict legal requirements and norms towards disinfection in different sectors, including food safety and blood transfusion, prompt high demand for pathogen reduction solutions. The increased rate of infections and new pathogens has led to a need for proper ways of controlling the pathogens. New developments in pathogen reduction technologies, which include increased efficiency in filtration processes and the development of additional chemical treatments, are opening up new market opportunities. More attention has been paid towards understanding the need to eliminate pathogens as a measure of enhancing product safety and quality in other industries.
Moreover, the seed capital and running costs of deploying state-of-the-art pathogen reduction technologies may be high for smaller firms. Integrating these pathogen reduction systems into a related process can be cumbersome and demands skills that lie in specialized niches. Difficulty in complying with divergent regulations and standards around the international arena is also likely to be a challenge for global players in this market. The use of nanomaterials in filtration systems is likely to raise the efficiency of pathogen removal. Two technologies called nanofiltration and ultrafiltration are also expected to grow in usage. They provide more precision and effectiveness in the elimination of pathogens. Probably, the most probable integration of multi-stage filtration will occur with membrane filtration in combination with UV or chemical treatment. Hybrid systems can ensure excellent control of pathogens without losing process efficiency.
Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/pathogen-reduction-system-market?utm_source=free&utm_medium=harsh
Definition of Pathogen Reduction System
Pathogen Reduction Systems (PRS): Technologies and processes that reduce the number of pathogens in biological and industrial products. These systems are used in transfusion safety, food and beverage processing, and pharmaceutical production.
Pathogen Reduction System Market Dynamics
Scope of the Pathogen Reduction System Market
The study categorizes the pathogen reduction system market based on technology, application, and end-user area at the regional and global levels.
By Technology Outlook (Sales, USD Million, 2019-2033)
- Chemical Methods
- Chlorination
- Ozonation
- Hydrogen Peroxide
- Physical Methods
- Ultraviolet (UV) Light
- Filtration
- Heat Treatment
- Biological Methods
- Biocides
- Enzyme-based Systems
By Application Outlook (Sales, USD Million, 2019-2033)
- Healthcare and Blood Transfusion
- Food and Beverage
- Pharmaceuticals
- Water Treatment
By End User Outlook (Sales, USD Million, 2019-2033)
- Hospitals and Blood Blanks
- Food and Beverage Industry
- Pharmaceutical Companies
- Municipalities and Water Treatment Facilities
By Region Outlook (Sales, USD Million, 2019-2033)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- Italy
- France
- UK
- Spain
- Poland
- Russia
- The Netherlands
- Norway
- Czech Republic
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Indonesia
- Malaysia
- Thailand
- Singapore
- Australia & New Zealand
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Colombia
- Rest of South America
- The Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Northern Africa
- Rest of MEA
Direct Purchase Report: https://www.marketstatsville.com/buy-now/pathogen-reduction-system-market?opt=3338&utm_source=free&utm_medium=harsh
Healthcare and Blood Transfusion segment accounts for the largest market share by Application
Based on the application, pathogen reduction systems (PRS) have become vital in health services and blood transfusions. These systems ensure that the blood products and medical equipment are safe and of high quality because they eliminate or reduce harmful pathogens to an extent that could be lethal or cause reactions if introduced into patients' bodies. Pathogen reduction technologies are gaining more importance in the healthcare and blood transfusion sectors due to increasingly stringent safety measures and a critical need to ensure that infectious diseases do not get transmitted. According to the Director General of Health Services, the pathogen reduction systems for blood transfusion have captured the market size worth around $1.2 billion by 2023. It includes the systems being used in the treatment of blood products to ensure safety. The United States FDA and European Medicines Agency impose very strict standards upon blood safety.
Additionally, Compliance with such regulations also drives the adoption of advanced pathogen reduction systems. Such growth is spurred by advances in technology, increased demand for safe blood products, and infection control awareness. Pathogen reduction technologies, such as advances in filtration techniques, chemical treatments, and irradiation methods, are helping the blood safety protocols in being more effective and efficient. Some of the developments that have resulted in bringing about the much-needed changes include ultraviolet (UV) light use and newer chemicals agents, which have increased the pathogen inactivation rates and have helped in this market growth.
North America accounted for the largest market share by Region.
Based on the region, North America region itself creates a need for advanced pathogen reduction technologies for blood transfusion and health care settings in North America, with strict regulations and standards led by FDA and CDC. Large-scale research and development along with innovation are strong drivers for the growth of this market. For developers and commercialisers, North America presents a hotbed for the development and commercialization of pathogen reduction technology. Such factors as well-structured infrastructure in healthcare and the growing demand for safe blood products as well as various medical devices drive the market considerably. North America continues to witness increased applications with UV-C light, as well as improved filtration systems that find applications in water treatments and sterilization of medical products.
Competitive Landscape: Pathogen Reduction System Market
The pathogen reduction system market is a huge competitor and very competitive in the market. It uses methods such as partnerships, product launches, acquisitions, agreements, and expansion to increase its position in the market. Most divisions of firms concentrate on expanding their operations globally and establishing durable partnerships.
Major players in the pathogen reduction system market are:
- Thermo Fisher Scientific Inc.
- Asahi Kasei Corporation
- Terumo BCT
- Pall Corporation (Danaher Corporation)
- Cerus Corporation
- Ecolab Inc.
- Octapharma
- Macopharma
- Sartorius AG
- Veolia Environnement S.A.
- Nordion
- Hologic, Inc.
Request For Report TOC: https://www.marketstatsville.com/table-of-content/pathogen-reduction-system-market
Recent Development
- In April 2024, Asahi Kasei announced its start of marketing a membrane system for the production of WFI, or a kind of sterile water used to prepare injections. The new membrane system was designed as an alternative to conventional distillation processes for the production of WFI by applying Microza hollow-fiber membrane design and development capabilities for water treatment and filtration of liquid products. By reducing the need to generate steam, this system enables lower CO2 emissions and lower costs in the production of WFI.
- In June 2024, Waters Corporation and Sartorius announced a new collaboration to develop integrated analytical solutions for downstream biomanufacturing, expanding their joint agreement that began with upstream bioprocessing analytics. Software and hardware integration available in the Waters™ PATROL™ UltraPerformance Liquid Chromatography (UPLC™) Process.
- In August 2024, New pathogen reduction system In this regard, Thermo Fisher has introduced a new pathogen reduction system for blood and plasma products. The system utilizes advanced filtration technology combined with UV-C light to enhance pathogen inactivation for the resolution of bacterial and viral contamination.
Comments
0 comment